There is great value to use of structural neuroimaging in the assessment of Alzheimer's disease (AD). However, to date, predictive value of structural imaging tend to range between 80% and 90% in accuracy and it is unclear why this is the case given that structural imaging should parallel the pathologic processes of AD. There is a possibility that clinical misdiagnosis relative to the gold standard pathologic diagnosis and/or additional brain pathologies are confounding factors contributing to reduced structural imaging classification accuracy. We examined potential factors contributing to misclassification of individuals with clinically diagnosed AD purely from cortical thickness measures. Correctly classified and incorrectly classified groups were compared across a range of demographic, biological, and neuropsychological data including cerebrospinal fluid biomarkers, amyloid imaging, white matter hyperintensity (WMH) volume, cognitive, and genetic factors. Individual subject analyses suggested that at least a portion of the control individuals misclassified as AD from structural imaging additionally harbor substantial AD biomarker pathology and risk, yet are relatively resistant to cognitive symptoms, likely due to "cognitive reserve," and therefore clinically unimpaired. In contrast, certain clinical control individuals misclassified as AD from cortical thickness had increased WMH volume relative to other controls in the sample, suggesting that vascular conditions may contribute to classification accuracy from cortical thickness measures. These results provide examples of factors that contribute to the accuracy of structural imaging in predicting a clinical diagnosis of AD, and provide important information about considerations for future work aimed at optimizing structural based diagnostic classifiers for AD.
. The current gold standard for a conclusive diagnosis of AD is through postmortem examination to identify the disease-defining regional patterns of neurofibrillary tau tangles and amyloid plaque deformities in the brain (Arnold, Hyman, Flory, Damasio, & Van Hoesen, 1991; Braak and Braak, 1991; Brun and Gustafson, 1976; Hardy, 2006; Hyman et al., 2012; Montine et al., 2012; Selkoe and Hardy, 2016) . Mild cognitive impairment (MCI) is considered as a potential intermediate stage between normal aging and AD. Individuals with an MCI diagnosis have an increased risk of developing AD and conversion rate is reported to be approximately 10%-15% per year (Petersen et al., 2001) . Although MCI is known to be a clinically heterogeneous condition, clinical diagnosis of probable AD is assumed to be a more stable condition that can be achieved with reasonable accuracy relative to the pathologic gold standard (Joachim, Morris, & Selkoe, 1988; Lopez et al., 2000) . However, clinical misdiagnosis relative to pathology can be substantial and depends on several factors. For example, a recent review across a total of 919 samples with at least one clinical visit and autopsy demonstrated that clinical diagnosis of probable and possible AD has a sensitivity ranged from 70.9% to 87.3% while specificity ranged from 44.3% to 70.8% relative to the pathological diagnosis (Beach, Monsell, Phillips, & Kukull, 2012) . The implication of this is that there is a relative uncertainty in the clinical diagnosis of AD as compared to the neuropathological diagnosis. Additionally, clinical diagnoses are often achieved late in the disease process when substantial brain tissue damage has resulted in noticeable cognitive deficit and other symptoms. Early clinical diagnosis is likely to have greater inaccuracy relative to the neuropathologic criteria (which is why diagnosis of MCI due to AD in the absence of biomarkers is particularly difficult). Given potential for clinical misdiagnosis and the need for early diagnostics, great emphasis has been put towards neuroimaging approaches for robust diagnosis of AD, prior to symptom development.
Structural imaging procedures have been successful in AD diagnostics (Chetelat and Baron, 2003; Frisoni, Fox, Jack, Scheltens, & Thompson, 2010; Park and Moon, 2016; Teipel et al., 2013) . This is due to the fact that structural atrophy mirrors patterns of the characteristic regional pathology of this condition (Jack, Petersen, O'brien, & Tangalos, 1992; Jack et al., 1997; Scheltens et al., 1992) . Several prior studies have applied structural imaging procedures in the later as well as earlier, and "preclinical" (e.g., MCI) stages of the disease Eskildsen et al., 2013; Fotenos, Snyder, Girton, Morris, & Buckner, 2005; Jack et al., 1999; Killiany et al., 2000 Killiany et al., , 2002 Scheltens, Fox, Barkhof, & De Carli, 2002) . Given current goals of clinical trials for identifying individuals in the earliest stages of disease, structural imaging could be advantageous as an initial screen for molecular procedures such as positron emission tomography which is currently used but costly and invasive.
AD detection using machine learning and magnetic resonance imaging (MRI) is a promising area of research. Support vector machines (SVM) is the most widely used procedure in neuroimaging studies to classify AD (Aguilar et al., 2013; Cuingnet et al., 2011; Kl€ oppel et al., 2008; Magnin et al., 2009; Salvatore, Battista, & Castiglioni, 2016; Schmitter et al., 2015; Vemuri et al., 2008; Wolz et al., 2011) . Although relatively successful, review of prior work demonstrates that there seems to be a "hard" limitation to accuracy with most studies reporting a range between 80 and 90%. There are two likely explanations for this limitation. First, to our knowledge, no prior work has been performed using a gold standard pathologic diagnosis and therefore all studies will have some degree of clinical misdiagnosis that contributes detrimentally to both the training and testing phases of classification. Second, it is likely that biological variability due in part to aging and other health and disease factors contribute to each individual's pattern of cortical thinning in a manner that may confound classification. To our knowledge, no prior studies have examined how these many factors contribute to machine learning classification accuracy of AD from structural MRI, however, recent studies have uncovered the need to consider age as a confounding factor contributing to misclassification of individuals with AD (Dukart et al., 2011; Falahati et al., 2016) . Little is currently known however about misclassification of AD from structural MRI when age is removed as a factor.
Current strategies for therapeutic clinical trials aim to identify individuals in the earliest stages of AD. Such a task should be greatly enhanced by structural imaging, yet it is critical to know factors that influence classification based on brain structure alone. Although it is possible to enhance classification through overfitting (e.g., including a range of variables in the classifier that are not thought to be directly related to AD pathology), this would in fact decrease the pathologic accuracy of the classification by including individuals with impairment due to other etiologies which would confound therapeutic trials aimed specifically at AD pathology. The goal of our work was to define factors that contribute to the known 10%-20% misclassification from structural MRI, as opposed to achieving the greatest possible accuracy in classification. Specifically, we aimed to identify demographic and biological factors that were most influential on the accuracy of classification of individuals with a clinical diagnosis of probable AD exclusively using regional cortical atrophy patterns given known links between cortical atrophy and regional patterns of AD histopathology. This work follows on recent efforts to optimally integrate biomarker information into the early and accurate diagnosis of individuals with pathologic AD (Falahati et al., 2016; Hwang et al., 2016; Jack et al., 2016; Landau et al., 2010; Mattsson et al., 2015; Palmqvist et al., 2015) .
Structural imaging was achieved with measurements of cortical thickness based on MRI which has been shown to index pathology in AD (Bakkour, Morris, & Dickerson, 2009; Dickerson et al., 2009; Lerch et al., 2008; McDonald et al., 2009; Salat et al., 2011) . Cortical thickness measurements are sensitive to subtle degenerative changes making this imaging marker an ideal feature for AD classification Eskildsen et al., 2013; Raamana et al., 2015; Wolz et al., 2011 (RAVLT) scores. We additionally examined the influence of white matter hyperintensity (WMH) burden on classification given this common type of brain tissue alteration in both typical aging as well as AD.
WMH are highly prevalent in older adults and in AD and are related to brain structural measures, and therefore may be an important factor related to classification accuracy (de Leeuw, 2001; Debette and Markus, 2010; Hopkins et al., 2006; Mortamais et al., 2013; Murray et al., 2005; Provenzano et al., 2013; Ylikoski et al., 1995) . Such information could be useful in determining whether misclassification was due to potential biological variability, clinical misdiagnosis, and/or technical limitations of the procedures and this information could be used toward further improvement of structural imaging procedures for the diagnosis of AD and provide potential insight into mechanisms of variability in cognitive expression of AD.
| M A TE RI A L S A ND M E TH ODS

| Dataset
We used the structural brain MRI scans from the Alzheimer's Disease Several studies have reported the effect of aging on global and regional brain changes in controls and AD (Lim, Zipursky, Murphy, & Pfefferbaum, 1990; Salat, Kaye, & Janowsky, 1999; Salat, Kaye, & Janowsky, 2001; Salat et al., 2004; Shear et al., 1995; Thompson et al., 1998) . As noted previously, age-related brain changes can potentially lead to misclassification of younger AD patients and older control individuals. We therefore created matched control and patient groups for age and other demographic factors. 100 subjects (50 Controls and 50 AD) matched for age, sex, and education were used in the surface based cortical thickness analysis and the remaining 306 subjects were used for classification. Subject demographics for the entire study and for the matched groups used for cortical thickness study are presented in Table 1 .
| Cortical thickness measurement
The FreeSurfer image analysis suite version 5.3.0 (http://surfer.nmr. mgh.harvard.edu) was employed to process the MRI data and compute cortical thickness measurements. The technical details of cortical reconstruction and volumetric segmentation performed with the Freesurfer are described in prior publications Dale and Sereno, 1993; Fischl, Sereno, & Dale, 1999a; Fischl, Sereno, Tootell, & Dale, 1999b; Fischl and Dale, 2000; Fischl, Liu, & Dale, 2001; Fischl et al., 2002 Fischl et al., , 2004a Fischl et al., , 2004b Han et al., 2006; Jovicich et al., 2006; Reuter, Rosas, & Fischl, 2010; Reuter, Schmansky, Rosas, & Fischl, 2012; Segonne et al., 2004) . Briefly, this processing includes motion correction and averaging of multiple volumetric T1 weighted images (M. Reuter et al., 2010) , removal of nonbrain tissue using a hybrid watershed/surface deformation procedure (Segonne et al., 2004) , automated Talairach transformation, segmentation of the subcortical white matter and deep gray matter volumetric structures (Fischl et al., , 2004a , intensity normalization (Sled, Zijdenbos, & Evans, 1998) , tessellation of the gray matter white matter boundary, automated topology correction (Fischl et al., 2001; Segonne, Pacheco, & Fischl, 2007) , and surface deformation following intensity gradients to optimally place the gray/white and gray/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class Dale and Sereno, 1993; Fischl and Dale, 2000) . Once the cortical models are complete, a number of deformable procedures can be performed for further data processing and analysis including surface inflation (Fischl et al., 1999a (Fischl et al., , 1999b ), registration to a spherical atlas which is based on individual cortical folding patterns to match cortical geometry across subjects (Fischl et al., 1999a (Fischl et al., , 1999b , parcellation of the cerebral cortex into units with respect to gyral and sulcal structure (Desikan et al., 2006; Fischl et al., 2004a) , and creation of a variety of surface based data including maps of curvature and sulcal depth. This method uses both intensity and continuity information from the entire three dimensional MR volume in segmentation and deformation procedures to produce representations of cortical thickness, calculated as the closest distance from the gray/white boundary to the gray/CSF boundary at each vertex on the tessellated surface (Fischl and Dale, 2000) . The maps are created using spatial intensity gradients across tissue classes and are therefore not simply reliant on absolute signal intensity. The maps produced are not restricted to the voxel resolution of the original data thus are capable of detecting submillimeter differences between groups. Procedures for the measurement of cortical thickness have been validated against histological analysis (Rosas et al., 2002) and manual measurements (Kuperberg et al., 2003; Salat et al., 2004) .
Thickness measurements were mapped on the inflated surface of each participant's reconstructed brain Fischl et al., 1999a Fischl et al., , 1999b . This procedure allowed visualization of data across the entire cortical surface (i.e., both the gyri and sulci) without interference from cortical folding. Maps were subsequently smoothed using a circularly symmetric Gaussian kernel across the surface with a full-width-halfmaximum (FWHM) of 10 mm. Next, cortical maps were averaged across participants using a nonrigid high-dimensional spherical averaging method to align cortical folding patterns (Fischl et al., 1999a (Fischl et al., , 1999b . This procedure provides accurate matching of morphologically homologous cortical locations among participants on the basis of each individual's anatomy while minimizing metric distortion, resulting in a mean measure of cortical thickness at each point on the reconstructed surface.
| Statistical analysis
Classifier features were selected as regions showing statistical thinning in the AD group compared to the control group. Whole-brain surfacebased general linear models were performed at each surface vertex (10,242 vertices per hemisphere). Resulting z-statistic maps were thresholded at p < .05. Multiple comparison correction was then performed using a clusterwise procedure (Hagler, Saygin, & Sereno, 2006) .
Surface data were corrected for multiple comparisons with a threshold of p < .0001 for both left and right hemispheres.
| Support vector machine classifier
Support vector machine is a commonly utilized supervised, multivariate classification method. The problem of AD detection using SVM was formulated as a binary classification problem. In brief, given an N observation samples {x i , y i }, where
the coded group label. If the sample belongs to that of an AD patient then the coded group label y i is defined as one (y i 51), otherwise, sample belongs to control where the coded group label is (y i 5 21). The SVM classifier finds a hyperplane maximizing the margin between groups. More details on SVM can be found in (Cortes and Vapnik, 1995; Sch€ olkopf and Smola, 2002) . In this study, we used the SVM implementation publicly available in LibSVM (csie.ntu.edu.tw/cjlin/ libsvm). To determine a suitable cost parameter C and kernel parameter g of the nonlinear Gaussian function in the SVM classifier, the parameter values are optimized using a cross-validation via grid-search approach (Chang and Lin, 2011 . The optimized set of parameters was then used to train the SVM classifier using the training set. The cortical thickness values obtained using surface based thickness analysis were used as features in the SVM and classifier was trained to predict the group membership on the remaining 306 subjects. A total of 22 features (cortical thickness regions) were used for classification. We used the 10-fold cross-validation to estimate the SVM classifier performance. During each fold, the classifier was developed using 90% of the subjects as training data and remaining 10% of the subjects as testing data. For better generalization, the classifier was tested for 100 different random combination of training and testing datasets.
| RE S U L TS
| Cortical thickness comparison between controls and AD
Cortical thickness measurements were obtained using FreeSurfer on 100 subjects (50 Controls and 50 AD) matched for age, gender, and education. As expected, group differences in cortical thickness between the controls and AD were robust and are demonstrated in Regions exhibiting significantly reduced cortical thickness in AD compared to controls following cluster-based multiple comparison correction based on the Freesurfer Desikan/Killiany parcellation atlas (Desikan et al., 2006) were entorhinal cortex, precuneus cortex, fusiform gyrus, banks of the superior temporal sulcus, inferior parietal cortex, supramarginal gyrus, superior frontal gyrus, inferior temporal gyrus, superior parietal cortex, superior temporal gyrus, middle temporal gyrus, rostral middle frontal gyrus, caudal middle frontal gyrus, and pars opercularis. Mean cortical thickness within each significant region was extracted from the remaining 306 subjects, and used as an input to the SVM classifier.
| Performance of SVM classifier
To illustrate the performance of the SVM classifier, mean cortical thickness values for each of the significant regions of interest were extracted from the remaining 306 subjects and used as features. A total of 22 features (cortical thickness regions) were used for classification.
We used the 10-fold cross-validation to obtain an unbiased estimate of the classifier performance. During each fold the classifier was developed using data from 90% of the subjects and tested using data from the remaining 10% of the subjects. For better generalization, the classifier was tested for 100 different random combination of training and testing datasets. The sensitivity, specificity, and accuracy were cal- 
| Analysis to determine factors contributing to misclassification
The results obtained using SVM classifier demonstrate that 10% of the subjects are misclassified based on structural imaging compared to their clinical diagnosis based on thickness values alone. These findings show that the procedures are robust for a large majority of the sample and therefore additional information about failures would better inform future implementations of SVM. Follow-up analyses examined potential factors that may contribute to any individual being misclassified. As noted, limitations in accuracy are potentially related to technical restrictions, incorrect clinical diagnosis or the confounding effects of demographic and/or health disparities rather than the method used for classification (Falahati, Westman, & Simmons, 2014 Cortical thickness. Given that the SVM is based on regional patterns of cortical thinning, it was expected that groups classified as having AD would have generally thinner cortex than groups classified as control.
However, it is unknown whether these results would be regionally selective or more global. Thus, although a somewhat circular analysis (given that the classifier was based on thickness values) we next compared age and sex matched groups using surface based thickness general linear models to better understand the spatial nature of the thickness patterns in the misclassified groups for illustrative purposes.
Surface maps of the cortical thickness differences between correctly classified controls and misclassified controls revealed reduced cortical thickness in misclassified controls in several cortical regions including use of spatial properties which differ in individuals with AD compared to controls. Thus, although these factors differ in the misclassified groups to some degree, the degree of heterogeneity prevents useful simple incorporation into the SVM classification procedure although future work will explore optimal parameters necessary for such incorporation. ANART score, typically used as an estimate of premorbid verbal intelligence and serves as a proxy of cognitive reserve (Katzman et al., 1988; Lo and Jagust, 2013; McGurn et al., 2004; Schmand, Smit, Geerlings, & Lindeboom, 1997; Stern et al., 1994; Stern, 2012 and also RAVLT learning scores were significantly different between the correctly classified AD and misclassified AD (p 5 .042). The RAVLT forgetting score, percentage of forgetting, and education level were not significantly different between classified and misclassified subjects.
In summary, the misclassified controls had higher ANART and poorer RAVLT performance relative to correctly classified controls. These results suggest that some portion of the misclassified controls may in fact be in early stages of impairment, potentially masked due to higher premorbid function. Misclassified AD may be in the earlier stages of impairment relative to correctly classified AD. Although the thinning pattern is indicative of early AD pathology, it should be noted that misclassified AD did not differ from correctly classified AD with regard to biomarker levels or cognition. It is unclear why this is, however, it is possible that the cortical thickness measures are more sensitively quantifiable than the cognitive or CSF values (i.e., a range of thickness values related to variation in pathology are linked to similar cognitive and CSF values). Alternatively, it is possible that the differences in thickness are linked to subtle differences in white matter lesion volumes, or similarly, that the misclassified AD are generally healthier in various other domains that may influence cortical thickness whereas the typical AD patient is less healthy generally.
At the individual subject level, the misclassified control (misclassified control with the highest CSF tau levels across all misclassified controls) had MMSE of 30, APOE4 positive, (18) F-AV45 positive, 0.51% white matter hyperintesity, 132 pg/ml amyloid-beta, and 156 pg/ml tau. One sample t test presented in Table 3 diagnosis and likely existence of AD pathology and also highlight factors that modulate the efficacy of the structural classification.
| D I SCUSSION
There is strong interest in AD "diagnostics" using machine learning and structural MRI (Cho et al., 2012; Coup e et al., 2012; Davatzikos, Bhatt, Shaw, Batmanghelich, & Trojanowski, 2011; Falahati et al., 2014; Kl€ oppel et al., 2015; Liu et al., 2012; Schouten et al., 2016; Westman et al., 2011a Westman et al., , 2011b Westman, Muehlboeck, & Simmons, 2012; Zhang et al., 2011) . These studies have demonstrated the obvious utility of structural imaging in this endeavor. Several studies have shown that hippocampal atrophy is an early indicator of AD (Jack et al., 1999; Killiany et al., 2002; Rana et al., 2017; Schr€ oder and Pantel, 2016) . The hippocampus has therefore been used in several prior classification studies (Chupin et al., 2009; Colliot et al., 2008; Frisoni et al., 1999) and is very effective to achieving classification to similar degrees as other structural measures. However, most prior studies aimed to The need for integration of biomarker information into the diagnosis of individuals with pathologic AD has been discussed extensively (Jack et al., 2016; Mattsson et al., 2015; Palmqvist et al., 2015) . These consensus papers suggest that amyloid-beta biomarkers, tau biomarkers, and biomarkers of neurodegeneration are necessary to identify early AD with high accuracy and would be useful to understand disease pathogenesis and expedite drug development. WMH are common type of brain tissue alteration in older adults, more prevalent in AD and are related to brain structural measures and therefore this tissue damage is an important factor related to diagnosis of AD. Several studies have investigated the association of WMH and cortical atrophy and generally found a higher degree of cortical atrophy among individuals with higher burden of WMH (Appelman et al., 2009; Capizzano et al., 2004; Godin et al., 2009; Raji et al., 2012) . There is increasing evidence of WMH association with cognitive decline (Prins and Scheltens, 2015; Provenzano et al., 2013; Rieckmann et al., 2016) . Recent studies have demonstrated interactions between WMH and cortical thickness and cognition (Jacobs, Clerx, Gronenschild, Aalten, & Verhey, 2014; Seo et al., 2012; Tuladhar et al., 2015) . In this study, we found misclas- utility of WMH in classification of AD, however, given that our goal here was to classify based on features considered to be linked to the primary pathology of AD, the inclusion of WMH to better match the clinical diagnosis would not necessarily help in achieving the goal of a pathologic classification.
Education and premorbid verbal intelligence typically serves as a proxy of cognitive reserve. Prior studies have shown association of the cognitive reserve markers with a lower risk of AD and memory decline (Buckner, 2004; Katzman et al., 1988; Lo and Jagust, 2013; Murray et al., 2011; Stern et al., 1994; Stern, 2012) . Premorbid intelligence assessed by ANART modifies the relationship between biomarkers of pathology and cognition in AD with individuals with high cognitive reserve having greater biomarker abnormalities than those with low cognitive reserve (Vemuri et al., 2011) . This study demonstrates mis- 
